Only 43% of European chief financial officers (CFOs) and chief information officers (CIOs) have tried to calculate the impact of outsourcing on their company, and of those that have tried, only 1 in 5 are confident about their calculations, according to a study by Cognizant, a global business technology company based in Teaneck, NJ.
Only 43% of European chief financial officers (CFOs) and chief information officers (CIOs) have tried to calculate the impact of outsourcing on their company, and of those that have tried, only 1 in 5 are confident about their calculations, according to a study by Cognizant, a global business technology company based in Teaneck, New Jersey. Meanwhile, more than one-third (37%) of those interviewed have not attempted to measure their return on investment from outsourcing, and 20% don't know whether they have tried to measure such a figure.
"Outsourcing has clear, long- and short-term benefits for businesses, but the research shows that many companies could be missing out by failing to adequately measure outsourcing's impact," said Sanjiv Gossain, vice-president and managing director for the UK and Ireland at Cognizant, in a company statement.
The survey was conducted in association with the United Kingdom’s Warwick Business School at Europe's largest companies between April and July of this year. According to Cognizant, outsourcing is an integral part of all pharmaceutical operations and more than $42 billion was spent on outsourcing deals in 2008.
However, many companies do not understand the real value of outsourcing. Measurement methods cited by CIOs and CFOs in the Cognizant survey were vague. Some comments, for example, included “manual calculation,” “You know what it costs, but you don't really know the value,” and "The accountants will use some formula for calculating return on investment."
"The report flags a critical gap in managerial knowledge, and some businesses clearly have to do better in justifying their significant outsourcing spend to the board," said Julia Kotlarsky, associate professor of information systems at Warwick, in the statement. "Outsourcers need to work closely with the CIO, CFO, and their teams to reduce the maintenance budgets and apply them to the proactive, revenue-generating activities the business demands to maximize the long-term business value of outsourcing engagements."
Stephanie Sutton is an assistant editor with PharmTech Europe.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.